Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

12345678910

LONDON BRIEFING: AstraZeneca earnings rise; J Sainsbury ups guidance

6th Nov 2025 07:51

(Alliance News) - AstraZeneca reports higher earnings, J Sainsbury raises its profit guidance and interim dividend while ITV warns of a tough advertising market. Read More

Hutchmed completes Saffron trial enrolment, results due 2026

5th Nov 2025 11:48

(Alliance News) - Hutchmed China Ltd on Wednesday said patient enrolment has been completed for its phase 3 Saffron trial evaluating the combination of Orpathys and Tagrisso in certain lung cancer patients, with topline results expected in the first half of 2026. Read More

LONDON MARKET CLOSE: Stocks mixed and pound dips amid budget tax hints

4th Nov 2025 16:59

(Alliance News) - The FTSE 100 outperformed European and US peers on Tuesday, but sterling fell further, as Chancellor Rachel Reeves laid the groundwork for further tax rises in this month’s budget. Read More

AstraZeneca hails phase 3 gefurulimab results in myasthenia gravis

31st Oct 2025 10:08

(Alliance News) - AstraZeneca PLC on Thursday said phase 3 data regarding its investigational inhibitor gefurulimab met its primary endpoint in myasthenia gravis activities of daily living. Read More

Daiichi Sankyo, AstraZeneca launch phase three Enhertu lung trial

31st Oct 2025 02:46

(Alliance News) - Daiichi Sankyo Co Ltd and AstraZeneca PLC on Friday said they began new phase 3 clinical trial testing of an intravenous treatment for advanced lung cancer. Read More

UK earnings, trading statements calendar - next 7 days

30th Oct 2025 16:16

Read More

AstraZeneca hails EU approval of Koselugo for form of neurofibromas

28th Oct 2025 09:36

(Alliance News) - AstraZeneca PLC on Tuesday said Alexion's selective inhibitor Koseluga has been approved in the EU for the treatment of symptomatic, inoperable plexiform neurofibromas, PN, in adult patients with neurofibromatosis type 1, NF 1. Read More

UK shareholder meetings calendar - next 7 days

27th Oct 2025 14:26

Read More

LONDON BROKER RATINGS: Jefferies raises GSK and AstraZeneca to 'buy'

27th Oct 2025 09:45

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

AstraZeneca hails EU approval of Tezspire for rhinosinusitis form

22nd Oct 2025 09:53

(Alliance News) - AstraZeneca PLC on Wednesday said its drug Tezspire has been approved in the European Union for the treatment of adult patients with chronic rhinosinusitis with nasal polyps. Read More

LONDON BROKER RATINGS: Goldman raises IAG; Peel Hunt raises XP Power

22nd Oct 2025 09:42

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More

AstraZeneca hails US FDA approval for Tezspire for rhinosinusitis form

20th Oct 2025 08:49

(Alliance News) - AstraZeneca PLC on Monday said its lupus drug Saphnelo received a positive opinion from the European Medicines Agency's committee for medicinal products for human use for a new subcutaneous formulation. Read More

LONDON BRIEFING: B&M cuts profit view; Astra drug gets FDA backing

20th Oct 2025 07:58

(Alliance News) - B&M European Value Retail cuts its profit guidance following an accounting error and says Chief Financial Officer Mike Schmidt will step down, while Bank of Ireland and Secure Trust Bank may increase provisions linked to the UK motor finance redress scheme. AstraZeneca announces a drug approval in the US. Read More

Daiichi, AstraZeneca report breast cancer gains with Enhertu, Datroway

20th Oct 2025 03:44

(Alliance News) - Daiichi Sankyo Co Ltd on Sunday reported promising clinical activity across multiple oncology programmes, including early signals in solid tumours and new data in breast cancer. Read More

Amgen and AstraZeneca says US FDA broadens indication for Tezspire

17th Oct 2025 21:44

(Alliance News) - Amgen Inc and AstraZeneca on Friday said the US Food & Drug Administration had broadened the indication for Tezspire to a second disease. Read More

AstraZeneca's Saphnelo gets nod in EU for systemic lupus erythematosus

17th Oct 2025 20:08

(Alliance News) - AstraZeneca PLC on Friday said Saphnelo subcutaneous self-administration has been recommended for approval in the European Union for systemic lupus erythematosus. Read More

AstraZeneca says Imfinizi lowers mortality risk in bladder cancer

17th Oct 2025 14:02

(Alliance News) - Astrazeneca PLC on Friday said that adding its Imfinzi drug to the treatment of bladder cancer was linked to lower mortality rates. Read More

LONDON MARKET OPEN: Stocks slump on US credit worries

17th Oct 2025 08:35

(Alliance News) - Stock prices in Europe traded sharply lower on Friday, with sentiment souring at the end of the week, and declines on the FTSE 100 were largely broad-based. Read More

LONDON MARKET MIDDAY: FTSE underperforms, pound shakes off tepid data

16th Oct 2025 12:15

(Alliance News) - Stocks in London struggled on the back of a tepid UK gross domestic product reading, but peers in Europe made strides and equities in New York are set to open higher. Read More

LONDON BROKER RATINGS: AstraZeneca cut; Barclays raises Centrica

16th Oct 2025 09:35

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: Read More

12345678910
FTSE 100 Latest
Value10,589.99
Change30.41